Village Farms Commends Trump for Rescheduling Marijuana to Schedule III
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 18 2025
0mins
Should l Buy VFF?
Village Farms commended U.S. President Donald Trump for his executive order directing the Attorney General to reschedule marijuana to a Schedule III drug under the Controlled Substances Act. Michael DeGiglio, founder, president, CEO of Village Farms commented, "We commend President Trump for his efforts to overcome decades of policy failures and bureaucratic red tape to advance meaningful reform that will help improve the lives of millions of Americans. We look forward to a better future in the United States in which federal cannabis policy follows scientific and medical research to unlock a new wave of investment and innovation in cannabinoid-based therapeutic products. Earlier this year, Village Farms' legal strategy in the DEA hearing process sought to prevent a failure to reschedule cannabis. We had a unique opportunity to represent our industry in the ALJ proceedings, and we're proud that our actions and advocacy efforts helped contribute to President Trump's thoughtful, evidenced based approach to enacting federal reform. We remain committed to collaborating with policymakers to advance commonsense reform for our seniors, military warriors, veterans, and medical patients, and believe our CBDistillery e-commerce platform, operational capabilities and U.S. production assets can help support increasing demand for safe, affordable medical cannabis products."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VFF?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VFF
Wall Street analysts forecast VFF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VFF is 5.00 USD with a low forecast of 5.00 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.000
Low
5.00
Averages
5.00
High
5.00
Current: 3.000
Low
5.00
Averages
5.00
High
5.00
About VFF
Village Farms International, Inc. is a vertically integrated supplier of plant-based consumer packaged goods in the cannabis and cannabidiol (CBD) categories in North America, the Netherlands, and selected markets internationally. Its segments include Produce, Cannabis-Canada, Cannabis-U.S., Clean Energy and Cannabis - Netherlands. Produce segment produces, markets and sells tomatoes, bell peppers and cucumbers. Cannabis-Canada produces and supplies cannabis products to be sold to other licensed providers and provincial governments across Canada and internationally. Cannabis-U.S. develops and sells CBD-based health and wellness products, including ingestible, edible and topical applications, across the United States. Clean Energy receives a royalty representing a portion of the natural gas that is sold to one customer pursuant to its long-term contract. Cannabis - Netherlands segment produces and supplies cannabis products in the Netherlands, supplying designated coffee shops.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Village Farms Wins BC Export Award for Consumer Products
- Outstanding Export Performance: Village Farms has been awarded the Consumer Products category at the 2026 BC Export Awards, highlighting its exceptional contribution to international trade and economic growth in British Columbia.
- Significant Sales Growth: As of September 30, 2025, the company achieved a 758% year-over-year increase in export sales, a testament to its disciplined, market-specific growth strategies and regulatory compliance expertise, showcasing its competitiveness in highly regulated markets.
- International Market Expansion: Village Farms exports medical cannabis to several international markets, including Germany, the UK, and Israel, through its EU-GMP certified operations, demonstrating its strong influence and growth potential in the global market.
- Solid Local Foundation: As one of the largest single-site agricultural employers in British Columbia, the company continues to invest locally, ensuring the consistency and high quality of its products in international markets, further solidifying its global competitiveness.
See More
Mid-to-Low Cap Consumer Staples Stocks Earn A+ EPS Revision Ratings
- Analyst Rating Upgrades: As earnings season begins, low-to-mid cap consumer staples stocks like The Andersons (ANDE) and Beyond Meat (BYND) have received an A+ EPS revision rating from analysts, indicating growing confidence in their profitability outlook.
- Improved Earnings Expectations: Companies such as Freshpet (FRPT) and John B. Sanfilippo & Son (JBSS) have shown strong performance in recent earnings estimate upgrades, suggesting an improvement in their fundamentals.
- Increased Market Attention: Firms like Oddity Tech (ODD) and Reynolds Consumer Products (REYN) are attracting investor interest due to their strong earnings momentum, with positive analyst revisions likely to drive stock price increases.
- Industry Trend Analysis: Companies such as Turning Point Brands (TPB) and Village Farms International (VFF) are performing well in the current market environment, demonstrating resilience in the consumer staples sector amid structural challenges.
See More
AdvisorShares Pure U.S. Cannabis ETF Momentum Surges to 88.95 Amid Policy Shifts
- Momentum Score Surge: The AdvisorShares Pure U.S. Cannabis ETF's momentum score skyrocketed from 24.75 to 88.95 in just over a week, reflecting strong market confidence in the cannabis sector, particularly following the Trump administration's policy shift to reclassify marijuana, which is expected to significantly enhance industry profitability.
- Profitability Enhancement: The reclassification allows companies like Tilray Brands Inc. to deduct standard business expenses, unlocking substantial cash flows that further drive investor interest in related stocks, contributing to a rally among the ETF's constituents in the new year.
- New Subsidiary Launch: Tilray has established Tilray Medical USA as its new medical subsidiary in response to the government's reclassification, aiming to tap into the “research-oriented national medical cannabis industry,” which will open new revenue streams and enhance market competitiveness.
- Favorable Market Trends: The AdvisorShares Cannabis ETF exhibits favorable price trends across short, medium, and long-term horizons, reflecting optimistic investor expectations for the future development of the cannabis industry, thereby solidifying its significance in investment portfolios.
See More
Village Farms Under Investigation, Stock Drops 9.3%
- Securities Fraud Investigation: Pomerantz LLP is investigating whether Village Farms International, Inc. has engaged in securities fraud or other unlawful business practices, which could undermine investor confidence and lead to stock volatility.
- License Denial Impact: On December 2, 2025, Village Farms disclosed it did not receive a conditional medical license from the Texas Department of Public Safety, resulting in a stock price drop of $0.37, or 9.3%, to close at $3.61, reflecting market concerns about the company's future prospects.
- Investor Advisory: Pomerantz LLP advises affected investors to contact their attorneys, indicating the potential for a class action lawsuit, which could further exacerbate market scrutiny regarding the company's compliance.
- Legal Firm Background: Pomerantz LLP is a prominent firm in securities and antitrust class litigation, established over 85 years ago, focusing on advocating for victims of securities fraud, highlighting the serious legal challenges Village Farms may face.
See More
Village Farms Under Investigation for Securities Fraud, Stock Drops 9.3%
- Investigation Launched: Pomerantz LLP is investigating whether Village Farms International, Inc. has engaged in securities fraud or other unlawful business practices, indicating potential legal risks that could undermine investor confidence.
- Stock Price Decline: Following the announcement on December 2, 2025, that Village Farms did not receive a conditional medical license from the Texas Department of Public Safety, its stock price fell by $0.37, or 9.3%, closing at $3.61 per share, reflecting market concerns about the company's future prospects.
- Legal Consequences: The investigation could lead to a class action lawsuit against Village Farms, and if found liable, the company may face substantial damages, further impacting its financial health and shareholder interests.
- Market Reaction: Investor trust in Village Farms has been shaken, potentially leading to difficulties in future financing and limiting the company's competitive capabilities in a rapidly changing market environment.
See More
Village Farms Under Investigation, Stock Drops 9.3%
- Securities Fraud Investigation: Pomerantz LLP is investigating whether Village Farms International, Inc. has engaged in securities fraud or other unlawful business practices, which could undermine investor confidence and lead to stock price volatility.
- Medical License Denial: On December 2, 2025, Village Farms disclosed that it did not receive a conditional medical license from the Texas Department of Public Safety, resulting in a stock price drop of $0.37, or 9.3%, to close at $3.61, reflecting market concerns about the company's future prospects.
- Investor Rights Protection: Pomerantz LLP, recognized for its expertise in securities litigation, may prompt more investors to join the class action, thereby increasing the legal risks faced by the company.
- Historical Litigation Background: With over 85 years in the securities class action field, Pomerantz LLP has successfully recovered multimillion-dollar damages for clients, showcasing its professional capability and influence in handling similar cases.
See More
Village Farms Wins BC Export Award for Consumer Products
- Outstanding Export Performance: Village Farms has been awarded the Consumer Products category at the 2026 BC Export Awards, highlighting its exceptional contribution to international trade and economic growth in British Columbia.
- Significant Sales Growth: As of September 30, 2025, the company achieved a 758% year-over-year increase in export sales, a testament to its disciplined, market-specific growth strategies and regulatory compliance expertise, showcasing its competitiveness in highly regulated markets.
- International Market Expansion: Village Farms exports medical cannabis to several international markets, including Germany, the UK, and Israel, through its EU-GMP certified operations, demonstrating its strong influence and growth potential in the global market.
- Solid Local Foundation: As one of the largest single-site agricultural employers in British Columbia, the company continues to invest locally, ensuring the consistency and high quality of its products in international markets, further solidifying its global competitiveness.
See More
Mid-to-Low Cap Consumer Staples Stocks Earn A+ EPS Revision Ratings
- Analyst Rating Upgrades: As earnings season begins, low-to-mid cap consumer staples stocks like The Andersons (ANDE) and Beyond Meat (BYND) have received an A+ EPS revision rating from analysts, indicating growing confidence in their profitability outlook.
- Improved Earnings Expectations: Companies such as Freshpet (FRPT) and John B. Sanfilippo & Son (JBSS) have shown strong performance in recent earnings estimate upgrades, suggesting an improvement in their fundamentals.
- Increased Market Attention: Firms like Oddity Tech (ODD) and Reynolds Consumer Products (REYN) are attracting investor interest due to their strong earnings momentum, with positive analyst revisions likely to drive stock price increases.
- Industry Trend Analysis: Companies such as Turning Point Brands (TPB) and Village Farms International (VFF) are performing well in the current market environment, demonstrating resilience in the consumer staples sector amid structural challenges.
See More
AdvisorShares Pure U.S. Cannabis ETF Momentum Surges to 88.95 Amid Policy Shifts
- Momentum Score Surge: The AdvisorShares Pure U.S. Cannabis ETF's momentum score skyrocketed from 24.75 to 88.95 in just over a week, reflecting strong market confidence in the cannabis sector, particularly following the Trump administration's policy shift to reclassify marijuana, which is expected to significantly enhance industry profitability.
- Profitability Enhancement: The reclassification allows companies like Tilray Brands Inc. to deduct standard business expenses, unlocking substantial cash flows that further drive investor interest in related stocks, contributing to a rally among the ETF's constituents in the new year.
- New Subsidiary Launch: Tilray has established Tilray Medical USA as its new medical subsidiary in response to the government's reclassification, aiming to tap into the “research-oriented national medical cannabis industry,” which will open new revenue streams and enhance market competitiveness.
- Favorable Market Trends: The AdvisorShares Cannabis ETF exhibits favorable price trends across short, medium, and long-term horizons, reflecting optimistic investor expectations for the future development of the cannabis industry, thereby solidifying its significance in investment portfolios.
See More
Village Farms Under Investigation, Stock Drops 9.3%
- Securities Fraud Investigation: Pomerantz LLP is investigating whether Village Farms International, Inc. has engaged in securities fraud or other unlawful business practices, which could undermine investor confidence and lead to stock volatility.
- License Denial Impact: On December 2, 2025, Village Farms disclosed it did not receive a conditional medical license from the Texas Department of Public Safety, resulting in a stock price drop of $0.37, or 9.3%, to close at $3.61, reflecting market concerns about the company's future prospects.
- Investor Advisory: Pomerantz LLP advises affected investors to contact their attorneys, indicating the potential for a class action lawsuit, which could further exacerbate market scrutiny regarding the company's compliance.
- Legal Firm Background: Pomerantz LLP is a prominent firm in securities and antitrust class litigation, established over 85 years ago, focusing on advocating for victims of securities fraud, highlighting the serious legal challenges Village Farms may face.
See More
Village Farms Under Investigation for Securities Fraud, Stock Drops 9.3%
- Investigation Launched: Pomerantz LLP is investigating whether Village Farms International, Inc. has engaged in securities fraud or other unlawful business practices, indicating potential legal risks that could undermine investor confidence.
- Stock Price Decline: Following the announcement on December 2, 2025, that Village Farms did not receive a conditional medical license from the Texas Department of Public Safety, its stock price fell by $0.37, or 9.3%, closing at $3.61 per share, reflecting market concerns about the company's future prospects.
- Legal Consequences: The investigation could lead to a class action lawsuit against Village Farms, and if found liable, the company may face substantial damages, further impacting its financial health and shareholder interests.
- Market Reaction: Investor trust in Village Farms has been shaken, potentially leading to difficulties in future financing and limiting the company's competitive capabilities in a rapidly changing market environment.
See More
Village Farms Under Investigation, Stock Drops 9.3%
- Securities Fraud Investigation: Pomerantz LLP is investigating whether Village Farms International, Inc. has engaged in securities fraud or other unlawful business practices, which could undermine investor confidence and lead to stock price volatility.
- Medical License Denial: On December 2, 2025, Village Farms disclosed that it did not receive a conditional medical license from the Texas Department of Public Safety, resulting in a stock price drop of $0.37, or 9.3%, to close at $3.61, reflecting market concerns about the company's future prospects.
- Investor Rights Protection: Pomerantz LLP, recognized for its expertise in securities litigation, may prompt more investors to join the class action, thereby increasing the legal risks faced by the company.
- Historical Litigation Background: With over 85 years in the securities class action field, Pomerantz LLP has successfully recovered multimillion-dollar damages for clients, showcasing its professional capability and influence in handling similar cases.
See More
